AKAM vs DVAX · P/E 27, rev $2.17B vs rev $277.2M
Akamai Technologies Inc (AKAM) versus Dynavax Technologies Corporation (DVAX) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. DVAX currently screens at market cap $1.82B.
Not investment advice. Open the AKAM and DVAX stock pages for the full models.
Not investment advice.